Literature DB >> 20034931

Smoking in prison: a hierarchical approach at the crossroad of personality and childhood events.

Stavroula A Papadodima1, Emmanouil I Sakelliadis, Theodoros N Sergentanis, Orestis Giotakos, Ioannis N Sergentanis, Chara A Spiliopoulou.   

Abstract

BACKGROUND: Smoking has long been considered part of prison culture and studies have shown a high prevalence of smoking within correctional facilities.
METHODS: A self-administered, anonymous questionnaire was administered to 173 male prisoners in the Chalkida prison, Greece. To assess current smoking habits, a hierarchical approach was adopted. The underlying conceptual framework included: (i) demographic parameters, (ii) adverse childhood history (physical abuse, parental neglect, parental divorce, alcoholism in the family, sexual abuse and psychiatric condition in the family), (iii) education, personality traits, such as impulsivity (Barrat Impulsivity Scale-11), aggression (Buss-Perry Aggression Questionnaire and Lifetime History of Aggression), and personal history of mental disease, (iv) prison-related features (duration of sentence, sentence already served and change in smoking habits during imprisonment).
RESULTS: Eighty percentage of the study sample reported current smoking; 43.4% disclosed deterioration in their smoking habits during imprisonment. The hierarchical approach pointed to: (i) adverse childhood events, i.e. alcoholism in the family [adjusted odds ratio (OR) = 6.29, 95% confidence interval (CI): 2.44-16.25], psychiatric condition in the family (adjusted OR = 4.10, 95% CI: 1.31-12.84), physical abuse (adjusted OR = 2.90, 95% CI: 1.30-6.46), parental neglect (adjusted OR = 2.66, 95% CI: 1.19-5.95), parental divorce (adjusted OR = 2.14, 95% CI: 1.00-4.56), and (ii) impulsivity (adjusted OR = 2.26, 95% CI: 1.12-4.58) as independent risk factors. In addition, deterioration of smoking habits during imprisonment exerted an effect of borderline significance (adjusted OR = 2.02, 95% CI: 0.97-4.24).
CONCLUSIONS: Heavy smoking in prison principally integrates two components: unfavourable childhood and current personality traits (impulsivity).

Entities:  

Mesh:

Year:  2009        PMID: 20034931     DOI: 10.1093/eurpub/ckp209

Source DB:  PubMed          Journal:  Eur J Public Health        ISSN: 1101-1262            Impact factor:   3.367


  6 in total

1.  Lifetime history of cigarette smoking associated with aggression and impulsivity in both healthy and personality disordered volunteers.

Authors:  Elias Dakwar; Marias Popii; Emil F Coccaro
Journal:  J Pers Disord       Date:  2011-10

2.  Prevalence and factors associated with smoking tobacco among men recently released from prison in California: A cross-sectional study.

Authors:  Benjamin A Howell; Joseph Guydish; Alex H Kral; Megan Comfort
Journal:  Addict Behav       Date:  2015-06-11       Impact factor: 3.913

3.  Effects of State-Level Tobacco Environment on Cigarette Smoking are Stronger Among Those With Individual-Level Risk Factors.

Authors:  Dvora Shmulewitz; Malka Stohl; Katherine M Keyes; Qiana Brown; Tulshi D Saha; Deborah Hasin
Journal:  Nicotine Tob Res       Date:  2016-04-29       Impact factor: 4.244

4.  COPD characteristics and socioeconomic burden in Hellenic correctional institutions.

Authors:  Eleni G Bania; Zoe Daniil; Chrysa Hatzoglou; Evangelos C Alexopoulos; Eirini Mitsiki; Konstantinos I Gourgoulianis
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-02-12

5.  Comparing Motivational Interviewing-Based Treatment and its combination with Nicotine Replacement Therapy on smoking cessation in prisoners: a randomized controlled clinical trial.

Authors:  Farzad Jalali; Reza Afshari; Ali Babaei; Hassan Abasspour; Mohammad Vahedian-Shahroodi
Journal:  Electron Physician       Date:  2015-10-19

6.  Burden and Determinants of Smoking among Prisoners with Respiratory Tract Infection: A Cross-Sectional Study of Nine Major Prison Setups in Northern Ethiopia.

Authors:  Semaw Ferede Abera; Kelemework Adane
Journal:  PLoS One       Date:  2016-12-28       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.